c) study utilized a cross sectional design to study changes in % FMD following a GLP-1-based therapy
All 49 individuals exposed to trial product were included in the analysis set
Further population-based studies may quantify incidence rates, characterize dose-dependent relationships, and investigate mechanistic pathways to optimize risk stratification and therapeutic decision-making
Employers should consider requiring documented diagnoses, evidence-based prior authorization, and stepped therapy, plus lifestyle programs before approving GLP-1s for weight loss to curb long-term spend
Some weight increase may occur during the washout period as your appetite returns and GLP-1's appetite-suppressing effects fade
Three minutes after placement into the chamber, rats were given three presentations of the tone conditioned stimulus (CS